Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Research site

EMED Centrum Uslug Medycznych Ewa Smialek

Poland Ul. Warszawska 5/7, 35-205 Rzeszow, Poland

  • 1 trial recruiting
  • Bronchiectasis · Asthmatic crisis · Asthma
  • Adults and children

About Specializations

EMED Centrum Uslug Medycznych Ewa Smialek in Rzeszow, Poland specialises in clinical trials of conditions such as Bronchiectasis, Asthmatic crisis, Asthma, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory Tract Diseases

The Medical Center at EMED Centrum Uslug Medycznych Ewa Smialek focuses on innovative research in respiratory tract diseases, aiming to improve outcomes for patients with chronic lung conditions.

  • Evaluation of a novel biologic therapy to lower oral corticosteroid reliance in asthma
  • Assessment of a new inhaled agent for reducing pulmonary exacerbations in bronchiectasis

Current studies target oral corticosteroid dependent asthma and bronchiectasis, testing whether emerging treatments can decrease medication burden and prevent flare‑ups, ultimately enhancing quality of life.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Warszawska 5/735-205 RzeszowPoland
Open in maps ↗
Recruiting now
1 trial
Conditions studied
3

More sites in RzeszowPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Bronchiectasis

Recruiting
Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bi 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.

Asthmatic crisis

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Human Igg1 Kappa Monoclonal Antibody Against Crlf2
  • Sponsor:Upstream Bio Inc.

Asthma

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.